Insulin Degludec is an ultra-long-acting insulin analogue
CAS.NO: 844439-96-9
Storage conditions: -15 or below, protected from light, sealed.
Product Description
Insulin Degludec is an ultra-long-acting insulin analogue. Previous studies have shown that it has an ultra-long-term hypoglycemic effect and can reduce the risk of hypoglycemia. At the 2011 meeting of the American Diabetes Association (ADA), a number of recent research results of Insulin Degludec were released to further explore its characteristics from molecular structure to hypoglycemic effect, showing that Insulin Degludec, which has a multi-hexamer configuration after subcutaneous injection, has stable pharmacokinetic characteristics, lasting, stable, long- term hypoglycemia and low risk of hypoglycemia.
Product Advantage
Meet the requirements of GMP specification.
Complete quality documents.
Packing Specification
10g/100g/500g
Storage conditions: -15 or below, protected from light, sealed.
Product Description
Insulin Degludec is an ultra-long-acting insulin analogue. Previous studies have shown that it has an ultra-long-term hypoglycemic effect and can reduce the risk of hypoglycemia. At the 2011 meeting of the American Diabetes Association (ADA), a number of recent research results of Insulin Degludec were released to further explore its characteristics from molecular structure to hypoglycemic effect, showing that Insulin Degludec, which has a multi-hexamer configuration after subcutaneous injection, has stable pharmacokinetic characteristics, lasting, stable, long- term hypoglycemia and low risk of hypoglycemia.
Product Advantage
Meet the requirements of GMP specification.
Complete quality documents.
Packing Specification
10g/100g/500g
Certificate
- ISO 9001
Main Products
Insulin Degludec, Insulin Aspart,Recombinant Trypsin